The Uncertain Path Forward for Psychedelic Medicine by Emily Mullin from Feed: All Latest on 2024-08-15 21:20 (#6Q0NT) After the FDA rejected its proposed MDMA treatment, Lykos Therapeutics is laying off 75 percent of its staff and its founder has left the company.
